Transient ECG Changes in Patients With Acute Biliary Disease

Sponsor
Ziv Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01706068
Collaborator
(none)
100
1
17.9
5.6

Study Details

Study Description

Brief Summary

Background:

The importance of ischemic ECG changes including St segment elevation, ST segment depression or T wave inversion that indicate myocardial ischemia are well established and require appropriate investigation and treatment.

However, there is an abundance of clinical situation, with apparently ischemic ECG change not indicate traditionally coronary artery related ischemia and therefore require prompt recognition and treatment of underlying condition, that may be serious and life-threatened. For example of such conditions are pericarditis, myocarditis, aortic dissection, electrolyte abnormalities, intracranial hemorrhage and hypothermia.

Together with them, an ECG ST segment changes may appeared in abdominal serious illness such as pancreatitis and cholecystitis(17,18,19,20,23). Whereas in pancreatitis various vasoactive and toxic for myocardium substances released, the cause of ST segment changes in cholecystitis are discussed and includes tachycardia , vagal reflexes, changed in plasma rennin activity resulted by distension of the gallbladder.

The certain proportion of the patients with ECG changes actually didn't have coronary artery disease(9,15) or other acute cardiac condition and therefore require treatment of the underlie illness only without spend the time for cardiac investigation or special treatment(1,3,4,7,8). Some kind of treatment may be even harmful for the patients with abdominal illness such as thrombolytic, anticoagulant, aggressive antiaggregant therapy or unnecessary cardiac catheterization.

In the medical literature the investigators found some case reports and works about the ECG changes in acute biliary disease in patient with knowing cardiac disease and without it, but actually incidence of ECG changes that suggest but not represent an acute coronary illness isn't knowing.

Therefore this is necessary to investigate actually incidence of ECG changes that mimic acute coronary syndrome in acute cholecystitis and acute biliary disease and determined clinical and laboratory characteristics that helps to differentiate this patients.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Transient ECG Changes in Patients With Acute Biliary Disease
    Study Start Date :
    Nov 1, 2012
    Anticipated Primary Completion Date :
    Nov 1, 2013
    Anticipated Study Completion Date :
    May 1, 2014

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 75 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      1. Patients from age 18 and up to 75years old.

      2. Causes of admission to the ED are acute cholecystitis, biliary colic, acute cholangitis

      3. The patient is willing to participate in the study and is able to sign an informed consent form.

      Exclusion Criteria:
      1. Elective hospitalization with known and not acute condition.

      2. Inability to give inform consent .

      3. Sepsis as complication of illness.

      4. Chronic ECG changes known by medical history.

      5. Knowing history of IHD.

      6. Previous cardiac catheterization with documented stenosis of at least 1 major coronary artery equal or more 50%.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Ziv Medical Center Zefat Israel 13100

      Sponsors and Collaborators

      • Ziv Hospital

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Inna Rozenfeld , MD, Principal Investigator, Ziv Hospital
      ClinicalTrials.gov Identifier:
      NCT01706068
      Other Study ID Numbers:
      • ECGCTIL
      First Posted:
      Oct 15, 2012
      Last Update Posted:
      Oct 15, 2012
      Last Verified:
      Oct 1, 2012
      Keywords provided by Inna Rozenfeld , MD, Principal Investigator, Ziv Hospital
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Oct 15, 2012